Related Experiment Videos
In vitro susceptibility studies with cefaclor and cephalexin
Antimicrobial Agents and Chemotherapy
|August 1, 1977
Abstract:
The in vitro activity of cefaclor and cephalexin against clinical isolates of four bacterial genera was compared. Both agents had a similar range of activity, but cefaclor was significantly more active by weight than cephalexin for most isolates tested.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A pseudo-outbreak of nosocomial infections associated with the introduction of an antibiotic management programme.
The Journal of hospital infection·2003
Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Excessive antibiotic use for acute respiratory infections in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Inhibition of type II NADH dehydrogenase in Mycobacterium tuberculosis reveals collateral vulnerability in the electron transport chain.
Antimicrobial agents and chemotherapy·2026
In vitro activity of zosurabalpin against a global set of carbapenem-resistant-A. baumannii clinical isolates.
Antimicrobial agents and chemotherapy·2026
N-terminal lysine as a critical determinant of odilorhabdin susceptibility to inactivation by the self-resistance acetyltransferase OatA.
Antimicrobial agents and chemotherapy·2026
Amphotericin B resistance in Lomentospora prolificans is associated with a soluble cell wall component.
Antimicrobial agents and chemotherapy·2026
Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein.
Antimicrobial agents and chemotherapy·2026
A Rat Excisional Wound Model for Investigating Therapeutics in Critical-Size Skin Wounds.
Journal of visualized experiments : JoVE·2026
Current evidence across the treatment spectrum of adrenocortical carcinoma: a comprehensive scoping review.
Endocrine oncology (Bristol, England)·2026
Combination of Palladium Nanoparticles and Tubastatin-A Potentiates Apoptosis in Human Breast Cancer Cells: A Novel Therapeutic Approach for Cancer [Retraction].
International journal of nanomedicine·2026